Skyscape Web Viewer : Skyscape Rx™ - Drug Guide : Use and Dosing

View All
Recurrent Aphthous Stomatitis (Not FDA approved)- thalidomide(adult)
Recurrent calcium oxalate calculi - allopurinol [Oral](adult)
Recurrent herpes labialis (cold sores) in immunocompetent adults- acyclovir [Buccal](adult)
Red back spider bite envenoming- antivenom red back spider (Australia) [IM](adult)
Red back spider bite envenoming- antivenom red back spider (Australia) [IM](peds)
Reduce risk of atherosclerotic events (MI, CVA, PVD) - clopidogrel(adult)
Reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation- apixaban(adult)
Reducing pain, inflammation, fever - ibuprofen(adult)
Reducing pain, inflammation, fever - ibuprofen(peds)
Reduction in breast cancer incidence in high risk women - tamoxifen(adult)
Reduction in risk of MI, stroke, and death from cardiovascular causes- ramipril(adult)
Reduction in risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation - rivaroxaban(adult)
Reduction in the risk of recurrence of DVT and of PE- rivaroxaban(adult)
Reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy- edetate calcium disodium [IM/IV](adult)
Reduction of blood loss from coronary artery bypass graft surgery - aprotinin [IV](adult)
Reduction of bone damage in bone metastases in breast cancer (Not FDA approved)- ibandronate [IV](adult)
Reduction of cerebral edema- magnesium sulfate [IM/IV](adult)
Reduction of duodenal ulcer risk (eradication of H. pylori)- esomeprazole [Oral](adult)
Reduction of elevated IOP- carbachol [Ophthalmic](adult)
Reduction of elevated IOP- tafluprost [Ophthalmic](adult)
Reduction of endometrial hyperplasia; postmenopausal women receiving estrogen- medroxyprogesterone [Oral](adult)
Reduction of facial hair in women- eflornithine [Topical](adult)
Reduction of intracaranial pressure- mannitol [IV](adult)
Reduction of intracaranial pressure- mannitol [IV](peds)
Reduction of intracranial pressure [Non-FDA Approved]- furosemide [IM/IV](adult)
Reduction of intracranial pressure [Non-FDA Approved]- furosemide [IM/IV](peds)
Reduction of intracranial pressure [Non-FDA Approved]- mannitol [IV](adult)
Reduction of intracranial pressure [Non-FDA Approved]- mannitol [IV](peds)
Reduction of IOP- mannitol [IV](adult)
Reduction of IOP- mannitol [IV](peds)